LY-4175408

N/A

Report date: 2026/04/18 20:00:19

Base Information

Drug NameLY-4175408
Drug Alias NameLY4175408LY-4175408
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker +[4] 
Mechanisms of ActionProtein-tyrosine kinase 7 inhibitorsDNA topoisomerase I inhibitors
TargetsProtein-tyrosine kinase 7DNA topoisomerase I
Therapy Area/IndicationsNeoplasm MetastasisEndometrial NeoplasmsSmall Cell Lung Carcinoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisEndometrial NeoplasmsSmall Cell Lung Carcinoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A